Odyssey Therapeutics, Inc. (ODTX)

Odyssey Therapeutics Revenue

Odyssey Therapeutics had revenue of $1.06M in the twelve months ending March 31, 2026. In the year 2025, Odyssey Therapeutics had annual revenue of $2.98M, down -33.45%.

• Revenue (ttm): $1.06M
• Revenue Growth: -33.45%
• P/S Ratio: 817.27
• Revenue / Employee: $10,580
• Employees: 100
• Market Cap: 864.68M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.98M	-1.50M	-33.45%
Dec 31, 2024	4.47M	3.44M	331.24%
Dec 31, 2023	1.04M	-	-
Dec 31, 2022	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jan 17, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 27, 2026

Data Sources Report a data error